Gemtero RTU 1gm Injection is a chemotherapy medication containing the active ingredient gemcitabine.
It is used to treat bladder cancer, breast cancer, ovarian cancer, pancreatic cancer, and non-small cell lung cancer.
Uses:
Bladder cancer (in combination with cisplatin).
Ovarian cancer (in combination with carboplatin).
Breast cancer (in combination with paclitaxel).
Pancreatic cancer.
Non-small cell lung cancer (NSCLC), alone or in combination with cisplatin.
Therapeutic Effects:
Gemtero RTU 1gm Injection blocks the ability of cancer cells to process DNA replication, which is essential for the cells to divide and grow. This can prevent or stop the growth of cancer cells.
Interaction with Other Drugs:
Inform your healthcare professional about all the medicines you take, including prescription medications, over-the-counter medications, nutritional and vitamin supplements, and herbal products. Certain medications interacting with Gemtero R1gm may reduce effectiveness by causing undesirable side effects.
Safety Advice:
Pregnancy: Gemtero RTU 1gm Injection can cause harm to your unborn baby. Tell your doctor if you are pregnant or planning to get pregnant before taking this treatment.
Breastfeeding: You must not breastfeed while being treated with Gemtero RTU 1gm Injection. Inform your doctor if you are breastfeeding before taking this injection.
Lungs: Gemtero RTU 1gm Injection is used cautiously in a patient with a lung disorder. Inform your doctor if you have any lung disease.
Liver: You need to tell your doctor if you have any liver disorders before taking Gemtero RTU 1gm Injection. Your doctor may decide to adjust the dose or delay treating you depending on your liver function.
Alcohol: It is not advised to take alcohol while under this treatment because Gemtero RTU 1gm may cause drowsiness and sleepiness.
Driving: Gemtero RTU 1gm Injection could affect your ability to drive. Avoid driving while taking this medicine.
Administration:
Gemtero RTU 1gm Injection is administered as an intravenous infusion into the vein.
If this injection is recommended for you, it will be given by a healthcare professional. Do not self-administer.
Your physician will choose the dosage and administration frequency based on the medical condition because it differs for each person.
Side Effects:
Serious: Pulmonary toxicity (shortness of breath, wheezing, cough), hemolytic-uremic syndrome (changes in the volume or colour of urine, increased bruising, or bleeding), pain or tenderness in the upper abdomen, allergic reactions, rashes, fever, swelling or sores in the mouth.
Common: Nausea, vomiting, low blood cell count, loss of appetite, hair loss, swelling of ankles, feet, and fingers, insomnia, constipation, diarrhea, headache, runny nose, chills, muscle pain, back pain, sweating, liver problems, blood in urine, abnormal urine test, oedema (swelling of ankles, fingers, feet, face).
Word of Advice:
It is not recommended to take Gemtero RTU 1gm Injection if you are allergic to Gemcitabine or any of its ingredients.
During this treatment, your doctor may periodically monitor your complete blood counts, blood sugar, electrolytes, liver panel, and kidney parameters to prevent serious complications.
This injection may impair fertility in male patients. Men taking this injection are advised not to father a child during the treatment and for 6 months after the treatment.
Consult your doctor before starting this injection, and it is advised to get suggestions about fertility concerns from your doctor.
It is advised for both men and women to follow proper contraceptive methods during and after the 6 months of the last dose.
FAQs:
How does Gemtero RTU 1gm affect cancer cells differ from healthy cells?
Gemtero RTU 1gm affects cancer cells more than healthy cells because cancer cells have a higher rate of DNA synthesis and replication than healthy cells. Gemtero RTU 1gm interferes with this process, which is essential for cancer cell growth and division, ultimately leading to the death of cancer cells.
Can Gemtero RTU 1gm be used to treat cancer in children?
No, Gemtero RTU 1gm injection is not recommended for adolescents and children under the age of 18.
What should I tell my doctor before starting Gemtero RTU 1gm treatment?
Patients should inform their doctor of any pre-existing medical conditions, allergies, or medications they are taking before starting Gemtero RTU 1gm treatment. It is also important to inform the doctor if you are pregnant, planning to become pregnant, or breastfeeding.
Are there any dietary or lifestyle changes that patients should make while taking Gemtero RTU 1gm?
Patients may need to make dietary or lifestyle changes while taking Gemtero RTU 1gm, such as avoiding certain foods or activities that may interfere with the medication's effectiveness or cause side effects. This should be discussed with a healthcare professional.
Does Gemtero RTU 1gm cure cancer?
Gemtero RTU 1gm can help slow the growth and spread of cancer cells, but it may not cure cancer on its own. It is often used in combination with other treatments, such as surgery, radiation therapy, or other chemotherapy medications, to improve the chances of a cure or long-term remission.
How long does Gemtero RTU 1gm treatment last?
The duration of Gemtero RTU 1gm treatment will depend on the type and stage of the cancer being treated, as well as the patient's overall health and response to the medication. Treatment may last several weeks or months.
